Skip to main content
FEBS Open Bio logoLink to FEBS Open Bio
. 2018 Dec 10;9(1):129–136. doi: 10.1002/2211-5463.12558

Presence of O‐glycosidically linked oligosaccharides in the cell wall mannan of Candida krusei purified with Benanomicin A

Takuya Kuraoka 1, Akito Ishiyama 2, Hiroko Oyamada 1, Yukiko Ogawa 1, Hidemitsu Kobayashi 1,
PMCID: PMC6325602  PMID: 30652080

Abstract

Cell wall mannan of the pathogenic yeast Candida krusei was prepared using the antibiotic Benanomicin A, which has a lectin‐like function. The chemical structure of this molecule was found to be similar to that of mannan prepared from the same yeast by the conventional method using Fehling reagent. Only a few degradation products were detected when the mannan prepared using Fehling reagent was subjected to alkali treatment (β‐elimination), but multiple α‐1,2‐linked oligosaccharides were detected when the mannan purified with Benanomicin A was treated with alkali. These results indicate that most of the O‐linked sugar chains in mannan were lost under conventional conditions when exposed to the strongly alkaline Fehling reagent. In contrast, the O‐glycosidic bond in mannan was not cleaved and the O‐linked sugar chains were maintained and almost intact following treatment with the mild novel preparation method using Benanomicin A. Therefore, we argue that the new mannan preparation method using Benanomicin A is superior to conventional methods. In addition, our study suggests that some yeast mannans, whose overall structure has already been reported, may contain more O‐linked sugar chains than previously recognized.

Keywords: antibiotic, Benanomicin A, Candida krusei, cell wall mannan, O‐linked sugar, β‐elimination


Abbreviations

Fr. K‐B

C. krusei mannan purified by Benanomicin method

Fr. K‐F

C. krusei mannan purified by Fehling method

NMR

nuclear magnetic resonance

M

d‐mannose residue

M2

biose

M3

triose

M4

tetraose

Invasive candidiasis represents the most common invasive fungal infection in the developed world. Mortality among patients with invasive candidiasis is very high 1. Candida albicans is the main pathogen of invasive candidiasis; however, during recent years, the rate of invasive candidiasis due to non‐albicans Candida species has increased 1, 2, 3. Two Candida species, C. krusei and C. glabrata, produce resistant strains against azole antifungal agents 4, 5. Accurate diagnosis is necessary to treat these infections with appropriate antibiotics, but rapid and easy diagnostic methods for identifying the species of genus Candida have not yet been clinically developed. One method for the identification of Candida yeast species is to detect a species‐specific gene. In addition, since the detection methods of genes are extremely sensitive, one risk is that Candida yeast species present in healthy people will also be detected. Therefore, another rapid diagnostic method for mycoses including endogenous infection may involve a classical immunochemical technique using an antigen–antibody reaction.

Tsuchiya et al. 6, 7, 8 previously analyzed the cell wall polysaccharide antigen of fungi including yeast of genus Candida. They revealed the presence of some specific antigens to fungi species and showed that these were useful for the identification of fungi species. Mannan is most important in the interaction between yeast and its host since this molecule is present in the outermost layer of the cell wall. For this reason, structural analysis studies of cell wall mannan of pathogenic Candida species have been an active area of research, and the overall structure and antigenic determinants of this molecule have been reported in several clinically important Candida species 9, 10.

One important requirement for the antigen analysis of Candida yeasts is the isolation of intact mannan molecules responsible for its antigenic activity. The most common procedure for purifying yeast‐derived mannan is by precipitating this molecule after it forms a complex with copper in Fehling reagent. We previously isolated various mannans from several pathogenic Candida yeasts by this procedure and analyzed the N‐linked polysaccharide moiety of these molecules and partial structure corresponding to various antigenic determinants 11, 12, 13, 14, 15, 16, 17. However, the use of the conventional mannan purification method using a strongly alkaline Fehling reagent results in a loss of O‐linked sugar chains from mannan. In fact, very small amounts of oligosaccharides can only be obtained using a dilute alkali treatment (β‐elimination) of mannans from various Candida yeast purified by the Fehling reagent 18, 19. As a result, most structural and immunochemical studies on yeast mannans so far have only mentioned the N‐linked sugar moiety of the molecule.

In the 1980s, a screen was performed by a pharmaceutical company that focused on polysaccharides specifically present on the surface of fungal cells, such as mannan, β‐glucan, and chitin. As a result, Benanomicin A, which has antifungal and anti‐HIV activities, has been isolated from the culture solution of Actinomadura sporax 20, 21, 22. The chemical structure of Benanomicin A (molecular weight, 864), an extremely dark red compound, is a glycoside composed of benzo [a] naphthacenequinone, d‐alanine, and a disaccharide (Fig. 1). Benanomicin A initiates antifungal action by selectively binding to the mannose residue of yeast cell wall mannan in the presence of Ca2+ 23. Therefore, Benanomicin A is regarded as an equivalent to lectin in its function even though it is not a protein.

Figure 1.

Figure 1

Chemical structure of Benanomicin A.

As mentioned above, C. krusei is a clinically important pathogenic yeast, but its immunochemical properties and chemical structure of its cell wall mannan remain unknown 7. The purpose of this study was to prepare cell wall mannan of C. krusei under rapid and mild conditions using Benanomicin A. We then demonstrated the presence of alkaline labile sugar chains in this molecule. These experimental results were then compared with those of conventional refining methods using the Fehling reagent.

Materials and methods

General

Candida krusei NBRC 0584 strain was obtained from the National Institute of Technology and Evaluation, Chiba, Japan. The yeast‐form cell of this strain was cultivated in Sabouraud liquid medium [0.5% (w/v) yeast extract, 1% (w/v) peptone, and 2% (w/v) glucose] for 48 h on a reciprocal shaker.

Benanomicin A was kindly provided by Dr. Shuichi Gomi (Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd., Tokyo, Japan).

Preparation of the crude extract of Candida krusei NBRC 0584 strain

The cells were harvested by centrifugation and washed with aqueous 0.9% (w/v) NaCl and then dehydrated with large volumes of acetone. The aqueous suspension of acetone‐dried cells was subjected to heat extraction at 130 °C for 3 hours. After cooling, the brown gel was concentrated in vacuo to a thick syrup and was dialyzed against running tap water for 48 h. The retentate was then concentrated in vacuo to a thin syrup, and the volume was adjusted to 20 mL with water. This solution was then lyophilized. The yield of the mannan crude extract was 18.5% (w/w) based on the acetone‐dried cell weight.

Purification of Candida krusei mannan by using Benanomicin A

Preparation of mannan using Benanomicin A was carried out following Fig. 2A. First, 25 mL of 0.2% (w/v) Benanomicin A in 0.2 m CaCl2 was added to the solution in which 500 mg of crude extract was dissolved, and under vigorous stirring. After 2 h, the resultant red precipitate was collected by centrifugation at 1450 g for 10 min, and the residue was rinsed with 25 mL of 0.2 m CaCl2 under vigorous stirring. The precipitate (Benanomicin A–mannan complex) was transferred to a 100‐mL beaker. Next, 20 mL of the aqueous solution of 0.2 m EDTA•2Na and mixed with 20 mL of 0.01 m HCl was mixed with the precipitate. After 10 min, the precipitin (Benanomicin A and EDTA‐Ca•2Na chelate) was removed by centrifugation at 1450 g for 10 min. The supernatant was neutralized with 0.1 m NaOH, dialyzed against running tap water for 48 h, concentrated in vacuo to 5 mL, and then lyophilized. The above‐mentioned method is referred to as the Benanomicin method, and C. krusei mannan purified by this method is abbreviated as ‘Fr. K‐B’.

Figure 2.

Figure 2

Procedure of Benanomicin method (A) and Fehling method (B).

Purification of Candida krusei mannan by the conventional method using Fehling reagent

As shown in Fig. 2B, mannan was prepared using Fehling reagent as previously described 24. Fehling reagent consists of a 1 : 1 (v/v) mixture of 3.5% CuSO4 5H2O, 17.3% Rochelle salt and 5.0% NaOH. This method is referred to as the Fehling method. Candida krusei mannan purified by this method is abbreviated as ‘Fr. K‐F’.

Treatment of Frs. K‐B and K‐F with alkali (β‐elimination)

Frs. K‐B and K‐F were dissolved in 30 mL of 0.1 m NaOH, respectively, and the solution was incubated at 25 °C for 18 h. Then, the solution was neutralized with 1 m HCl, concentrated to a small volume, applied to a Bio‐Gel P‐2 column (2.5 × 100 cm) (Bio‐Rad, Tokyo, Japan), and eluted with water (0.25 mL·min−1).

Other methods

Total carbohydrate content was determined by the phenol‐H2SO4 method 25 using d‐mannose as a standard. Total protein content was determined by the Folin method 26 using bovine serum albumin as a standard. Total phosphate content was determined by the method of Ames‐Dubin 27 using KH2PO4 as the standard. The 1H‐NMR spectra were recorded by means of a JEOL JNM‐AL400 spectrophotometer in D2O solution at 70 °C, using acetone as the standard (2.217 ppm).

Results

Establishment a purification method of mannan by using Benanomicin A

In order to establish a purification method for mannan from the yeast cell wall utilizing the lectin‐like activity of antibiotic Benanomicin A, various conditions were examined (data not shown). Consequently, we propose a new method as shown in Fig. 2A. This method does not require exposure to a strong alkaline environment like the conventional Fehling method (Fig. 2B). Thus, the Benanomicin method not only provides mild conditions for the purification of mannans, but also reduced the procedure time (Fig. 2A).

Chemical analysis of Frs. K‐B and K‐F

Yields of Frs. K‐B and K‐F were 54.7 and 30.1% (w/w), respectively, based on the crude extract. This fact indicates that C. krusei mannan molecules bind efficiently to Benanomicin A rather than Fehling regent, resulting in the formation of a precipitate. The chemical compositions of Frs. K‐B and K‐F are shown in Table 1. Phosphorus was not detected in any fraction, but both K‐B and K‐F fractions contained small amounts of protein. The protein content of Fr. K‐B was higher than that of Fr. K‐F, suggesting that the mild conditions of the Benanomicin method resulted in less damage to the protein.

Table 1.

Chemical compositions of Candida krusei mannan fractions. K‐B and K‐F

Mannan Total carbohydratea (%) Total proteinb (%) Total phosphatec (%) Yieldd (%)
Fr. K‐B 88.8 9.1 0 54.7
Fr. K‐F 94.9 3.4 0 30.1
a

Determined by phenol‐H2SO4 method using d‐mannose as a standard.

b

Determined by BCA protein assay using bovine serum albumin as a standard.

c

Determined by Ames‐Dubin method using KH2KO4 as a standard.

d

Weight based of crude extract.

1H‐NMR analysis of Frs. K‐B and K‐F

To obtain information on the sugar chain structure, which is a major component of Frs. K‐B and K‐F, 1H‐NMR analysis was carried out (Fig. 3). The spectra of both fractions showed extremely similar patterns in the anomeric proton region (range of 4.7–5.7 ppm). This finding suggests that the new purification method of yeast mannan was just as effective as conventional methods. The absence of any signal in the range of 5.40–5.70 ppm indicated that both fractions did not contain mannose residues via a phosphodiester bond. Four strong signals derived from α‐1,2‐ and α‐1,6‐linked mannose residues (5.220, 5.203, 5.086, and 5.055 ppm), and three weak signals derived from an α‐1,3‐linked mannose residue (5.254, 5.158, and 5.027 ppm) were observed in both fractions. In summary, based on our previous report 12, it became clear that cell wall mannan of C. krusei cell does not contain a β‐1,2‐linked mannose residue and phosphodiester bond.

Figure 3.

Figure 3

1H‐NMR spectra (anomeric region) of Candida krusei mannan, Frs. K‐B (A) and K‐F (B).

Alkali treatment (β‐elimination) of Frs. K‐B and K‐F

As shown in Fig. 4, to identify alkaline labile sugar chains in C. krusei mannan, Frs. K‐B and K‐F were subjected to dilute alkali treatment, and their products were fractionated by gel chromatography. The yields of oligosaccharides released from Frs. K‐B and K‐F were 20.0 and 1.4% (w/w), respectively. This finding proves that most of the O‐glycosidic sugar chains in the C. krusei mannan molecule were lost at the purification stage by the Fehling method. In other words, the Benanomicin method can be used to isolate mannan in their original form without hydrolysis of O‐glycosidic bonds. The products of Fr. K‐B after the alkaline treatment consisted of low‐molecular‐weight oligosaccharides, tetraose (M4), triose (M3), and biose (M2), as well as minimal amounts of mannose. On the other hand, in the same treatment of Fr. K‐F, only biose was able to collect an analyzable amount in the next NMR. The 1H‐NMR spectra of these oligosaccharides are shown in Fig. 5. Based on our previous findings 28, we determined that all of these oligosaccharides were composed only of α‐1,2‐linked mannose residues. Namely, M4, M3, and M2 were identified as Manα1‐2Manα1‐2Manα1‐2Man, Manα1‐2Manα1‐2Man, and Manα1‐2Man, respectively.

Figure 4.

Figure 4

Elution profiles of oligosaccharides obtained from Frs. K‐B (A) and K‐F (B) by the alkali treatment (β‐elimination). M4, M3, M2, and M indicate the eluted positions of standard mannooligosaccharides, tetraose, triose, biose, and mannose, respectively.

Figure 5.

Figure 5

1H‐NMR spectra of oligosaccharides obtained from Frs. K‐B (A) and K‐F (B) by the alkali treatment (β‐elimination). M4, M3, and M2 indicate tetraose, triose, and biose, respectively.

Discussion

In this study, we determined that sugar chains linked to the hydroxyl group of serine and/or threonine in the mannan–protein complex (mannan) derived from C. krusei NBRC 0584 were low‐molecular‐weight oligosaccharides composed only of α‐1,2‐linked mannose residues (Fig. 6). In addition, the chemical structure of the sugar chains linked to the amino group of asparagine of this mannan was composed of α‐1,2‐, α‐1,3‐, and α‐1,6‐linked mannose residues. Although the carbohydrate domain of C. krusei mannan appeared to be composed of about 20% O‐linked sugar chains and about 80% N‐linked sugar chains (Table 1), the detailed chemical structure of this N‐linked sugar chain has not been reported yet. Our unpublished research data showed that the C. krusei mannan structure was distinct from the comb‐like structure presented by mannans of other Candida species and therefore further studies are required.

Figure 6.

Figure 6

Structure of O‐linked sugar chains in the cell wall mannan of Candida krusei. Ser, Thr, Asn and M indicate serine, threonine, asparagine and mannose, respectively. *The chemical structure of N‐linked sugar chains in this mannan is not clear yet.

Previous immunochemical studies of pathogenic Candida yeast mostly targeted N‐linked sugar chains of cell surface mannan. In these previous reports 9, 10, 29, the Fehling method was used to prepare cell wall mannan. However, since the mannan molecule was exposed to a strong alkaline solution in the Fehling method, the final form of mannan lacks the O‐linked sugar chain. Therefore, the proportion of O‐linked sugar chain in the yeast cell wall mannan molecule may be considerably larger than that previously recognized. Therefore, it may be necessary to revalidate the antigenic structure of surface polysaccharides of several Candida species other than C. krusei by adopting the Benanomicin method established in this report.

In recent studies on the infection mechanism of Candida yeasts to the host, mutant strains lacking the PMT or MNT gene family encoding the protein O‐mannosyltransferase or α‐1,2‐mannosyltransferase, respectively, involved in the biosynthesis of O‐linked sugar chains are frequently used. In these reports on bioactivities such as adhesion to host cells 30, 31, lethal activity of experimental animals 31, impact on host cellular immune response 32, 33, resistance to antibiotics 34 and formation of biofilm 35, the important roles of O‐linked sugar chains in the mannan molecule have been discussed. However, in order to investigate whether the O‐linked sugar chain in mannan was directly involved in the Candida infection mechanism or the biological activity of mannan molecule, it is necessary to successfully isolate the mannan molecule from the wild‐type pathogen by β‐elimination and utilize the resultant sugar chain as an inhibitor for each biological reaction system. Therefore, to elucidate these mechanisms, the new mannan preparation methods using Benanomicin A established in this report would be of great use.

Author contributions

HK conceived and supervised the study. HO, AI, YO, and TK performed experiments. TK and HK wrote the manuscript.

Conflict of interest

The authors declare no conflict of interest.

References

  • 1. Hegazi M, Abdelkader A, Zaki M and EI‐Deek B (2014) Characteristics and risk factors of candidemia in pediatric intensive care unit of a tertiary care children's hospital in Egypt. J Infect Dev Ctries 8, 624–634. [DOI] [PubMed] [Google Scholar]
  • 2. Gokcebay DG, Yarali N, Isik P, Bayram C, Ozkaya‐Parlakay A, Kara A and Tunc B (2016) Candida associated bloodstream infections in pediatric hematology patients: a single center experience. Mediterr J Hematol Infect Dis 8, 1–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Kakeya H, Yamada K, Kaneko Y, Yanagihara K, Tateda K, Maesaki S, Takesue Y, Tomono K, Kadota JI, Kaku M et al (2018) National trends in the distribution of Candida species causing Candidemia in Japan from 2003 to 2014. Med Mycol J 59, E19–E22. [DOI] [PubMed] [Google Scholar]
  • 4. Johnson LB and Kauffman CA (2003) Voriconazole: a new triazole antifungal agent. Clin Infect Dis 36, 630–637. [DOI] [PubMed] [Google Scholar]
  • 5. Pfaller MA, Moet GJ, Messer SA, Jones RN and Castanheira M (2011) Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009). J Clin Microbiol 49, 396–399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Tsuchiya T, Fukazawa Y and Kawakita S (1965) Significance of serological studies on yeasts. Mycopathol Mycol Appl 26, 1–15. [DOI] [PubMed] [Google Scholar]
  • 7. Tsuchiya T, Fukazawa Y, Taguchi M, Nakase T and Shinoda T (1974) Serological aspects on yeast classification. Mycopathol Mycol Appl 53, 77–91. [DOI] [PubMed] [Google Scholar]
  • 8. Fukazawa Y, Shinoda T and Tsuchiya T (1968) Response and specificity of antibodies for Candida albicans . J Bacteriol 95, 754–763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Suzuki S, Shibata N and Kobayashi H (1991) Immunochemistry of Candida mannan. NATO ASI Series H53, 111–121. [Google Scholar]
  • 10. Shibata N, Kobayashi H and Suzuki S (2012) Immunochemistry of pathogenic yeast, Candida species, focusing on Mannan. Proc Jpn Acad Ser B Phys Biol Sci 88, 250–265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Shibata N, Fukasawa S, Kobayashi H, Tojo M, Yonezu T, Ambo A, Ohkubo Y and Suzuki S (1989) Structural analysis of phospho‐D‐mannan–protein complexes isolated from yeast and mold form cells of Candida albicans NIH A‐207 serotype A strain. Carbohydr Res 187, 239–253. [DOI] [PubMed] [Google Scholar]
  • 12. Kobayashi H, Shibata N, Nakada M, Chaki S, Mizugami K, Ohkubo Y and Suzuki S (1990) Structural study of cell wall phosphomannan of Candida albicans NIH B‐792 (serotype B) strain, with special reference to 1H and 13C NMR analyses of acid‐labile oligomannosyl residues. Arch Biochem Biophys 278, 195–204. [DOI] [PubMed] [Google Scholar]
  • 13. Kobayashi H, Mitobe H, Takahashi K, Yamamoto T, Shibata N and Suzuki S (1992) Structural study of a cell wall mannan–protein complex of the pathogenic yeast Candida glabrata IFO 0622 strain. Arch Biochem Biophys 294, 662–669. [DOI] [PubMed] [Google Scholar]
  • 14. Kobayashi H, Shibata N and Suzuki S (1992) Evidence for oligomannosyl residues containing both β‐1,2 and α‐1,2 linkages as a serotype A‐specific epitope(s) in mannans of Candida albicans . Infect Immun 60, 2106–2109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Shibata N, Arai M, Haga E, Kikuchi T, Najima M, Satoh T, Kobayashi H and Suzuki S (1992) Structural identification of an epitope of antigenic factor 5 in mannans of Candida albicans NIH B‐792 (serotype B) and J‐1012 (serotype A) as β‐1,2‐linked oligomannosyl residues. Infect Immun 60, 4100–4110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Kobayashi H, Oyamada H, Suzuki A, Shibata N, Suzuki S and Okawa Y (1996) Identification of the antigenic determinants of factors 8, 9, and 34 of genus Candida . FEBS Lett 395, 109–112. [DOI] [PubMed] [Google Scholar]
  • 17. Shibata N, Akagi R, Hosoya T, Kawahara K, Suzuki A, Ikuta K, Kobayashi H, Hisamichi K, Okawa Y and Suzuki S (1996) Existence of novel branched side chains containing beta‐1,2 and alpha‐1,6 linkages corresponding to antigenic factor 9 in the mannan of Candida guilliermondii . J Biol Chem 271, 9259–9266. [DOI] [PubMed] [Google Scholar]
  • 18. Kobayashi H, Matsuda K, Ikeda T, Suzuki M, Takahashi S, Suzuki A, Shibata N and Suzuki S (1994) Structures of cell wall mannans of pathogenic Candida tropicalis IFO 0199 and IFO 1647 yeast strains. Infect Immun 62, 615–622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Kobayashi H, Komido M, Watanabe M, Matsuda K, Suzuki M, Ikeda T, Oyamada H, Shibata N and Suzuki S (1994) Structure of cell wall mannan of Candida kefyr IFO 0586. Infect Immun 62, 4425–4431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Takeuchi T, Hara T, Naganawa H, Okada M, Hamada M, Umezawa H, Gomi S, Sezaki M and Kondo S (1988) New antifungal antibiotics, benanomicins A and B from an Actinomycete . J Antibiotics 41, 807–811. [DOI] [PubMed] [Google Scholar]
  • 21. Hoshino H, Seki J and Takeuchi T (1989) New antifungal antibiotics, benanomicins A and B inhibit infection of T‐cell with human immunodeficiency virus (HIV) and syncytium formation by HIV. J Antibiotics 42, 344–346. [DOI] [PubMed] [Google Scholar]
  • 22. Kondo S, Gomi S, Ikeda D, Hamada M, Takeuchi T, Iwai H, Seki J and Hoshino H (1991) Antifungal and antiviral activities of benanomicins and their analogues. J Antibiotics 44, 1228–1236. [DOI] [PubMed] [Google Scholar]
  • 23. Watanabe M, Gomi S, Tohyama H, Ohtsuka K, Shibahara S, Inouye S, Kobayashi H, Suzuki S, Kondo S, Takeuchi T et al (1996) Binding of Benanomicin A to fungal cells in reference to its fungicidal action. J Antibiotics 49, 366–373. [DOI] [PubMed] [Google Scholar]
  • 24. Okubo Y, Ichikawa T and Suzuki S (1978) Relationship between phosphate content and immunochemical properties of subfractions of bakers’ yeast mannan. J Bacteriol 136, 63–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. DuBois M, Gilles KA, Hamilton JK, Rebers PA and Smith F (1956) Colorimetric method for determination of sugars and related substances. Anal Chem 28, 350–356. [DOI] [PubMed] [Google Scholar]
  • 26. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265–275. [PubMed] [Google Scholar]
  • 27. Ames BN and Dubin DT (1960) The role of polyamines in the neutralization of bacteriophage deoxyribonucleic acid. J Biol Chem 235, 769–775. [PubMed] [Google Scholar]
  • 28. Kobayashi H, Kawakami S, Ogawa Y, Shibata N and Suzuki S (2013) Isolation of mannooligosaccharides corresponding to antigenic determinants of pathogenic yeast Candida catenulata cell wall mannan. Adv Microbiol 3, 222–226. [Google Scholar]
  • 29. Fukazawa Y, Elinov NP, Shinoda T and Tsuchiya T (1968) Immunological specificity of soluble polysaccharides of Candida albicans . Jpn J Microbiol 12, 283–292. [DOI] [PubMed] [Google Scholar]
  • 30. Buurman ET, Westwater C, Hube B, Brown AJ, Odds FC and Gow NA (1998) Molecular analysis of CaMnt1p, a mannosyltransferase important for adhesion and virulence of Candida albicans . Proc Natl Acad Sci USA 95, 7670–7675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Timpel C, Strahl‐Bolsinger S, Ziegelbauer K and Ernst JF (1998) Multiple functions of Pmt1p‐mediated protein O‐mannosylation in the fungal pathogen Candida albicans . J Biol Chem 273, 20837–20846. [DOI] [PubMed] [Google Scholar]
  • 32. Bain JM, Louw J, Lewis LE, Okai B, Walls CA, Ballou ER, Walker LA, Reid D, Munro CA, Brown AJ et al (2014) Candida albicans hypha formation and mannan masking of β‐glucan inhibit macrophage phagosome maturation. MBio 5, e01874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Pérez‐García LA, Csonka K, Flores‐Carreón A, Estrada‐Mata E, Mellado‐Mojica E, Németh T, López‐Ramírez LA, Toth R, López MG, Vizler C et al (2016) Role of protein glycosylation in Candida parapsilosis cell wall integrity and host interaction. Front Microbiol 7, 306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Timpel C, Zink S, Strahl‐bolsinger S, Schröppel K and Ernst J (2000) Morphogenesis, adhesive properties, and antifungal resistance depend on the Pmt6 protein mannosyltransferase in the fungal pathogen Candida albicans . J Bacteriol 182, 3063–3071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Dutton LC, Nobbs AH, Jepson K, Jepson MA, Vickerman MM, Aqeel Alawfi S, Munro CA, Lamont RJ and Jenkinson HF (2014) O‐mannosylation in Candida albicans enables development of interkingdom biofilm communities. MBio 5, e00911. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from FEBS Open Bio are provided here courtesy of Wiley

RESOURCES